After listening to Jay Campbell feedback regarding Huberman, I come to believe that Huberman don’t know Jack shit about peptides reading for my Teleprompter. That’s pretty sad. I thought he was a lot smarter than that, but he doesn’t know nothing.

Huberman has demonstrated substantial knowledge about peptides, their uses, and their risks.

• Sermorelin and tesamorelin: He described his experience with sermorelin, including deeper sleep but less REM sleep in his case, and explained that tesamorelin is FDA-approved to reduce visceral fat in people with HIV. 1
• CJC-1295 risks: He discussed a cardiovascular death during a CJC-1295 clinical trial, along with possible fluid retention, and cautioned that the safety questions remain unresolved. 2
• What peptides are and why names confuse: He explained that peptides are amino-acid sequences that can mimic hormones or other peptides, and laid out different peptide categories while noting how acronyms and similar names cause confusion. 3 4
• Safety and responsible use: He emphasized that peptide risks vary, warned against contaminated online sources and black-market products, and recommended medical guidance and quality sourcing; he also discussed risks such as tumor growth when stimulating growth-hormone pathways. 5 6